Presentation

The First Bancshares to Participate in the 2021 HOVDE Group Financial Services Conference

Retrieved on: 
Wednesday, November 3, 2021
Professional Services, Communications, Other Professional Services, Finance, Banking, Public Relations, Investor Relations, FBMS, First, Association, NASDAQ, Presentation, Arizona Biltmore Hotel, Conference, Investor relations, Nasdaq

The First Bancshares, Inc. (NASDAQ: FBMS), holding company for The First, A National Banking Association, ( www.thefirstbank.com ) announced that company representatives will participate in the 2021 HOVDE Group Financial Services Conference, which is being held November 3, 2021 through November 5, 2021 in Phoenix, Arizona at the Arizona Biltmore, and will have one-on-one meetings with certain bank stock analysts and investors beginning on November 4, 2021.

Key Points: 
  • The First Bancshares, Inc. (NASDAQ: FBMS), holding company for The First, A National Banking Association, ( www.thefirstbank.com ) announced that company representatives will participate in the 2021 HOVDE Group Financial Services Conference, which is being held November 3, 2021 through November 5, 2021 in Phoenix, Arizona at the Arizona Biltmore, and will have one-on-one meetings with certain bank stock analysts and investors beginning on November 4, 2021.
  • The presentation prepared for use during these meetings will be available at the companys website www.thefirstbank.com under Investor Relations>Presentations and Press Releases>Presentations.
  • The First Bancshares, Inc., headquartered in Hattiesburg, Mississippi, is the parent company of The First, A National Banking Association.
  • Founded in 1996, the First has operations in Mississippi, Louisiana, Alabama, Florida and Georgia.

LogicBio Therapeutics to Present New GeneRide™ Data at the European Society of Gene and Cell Therapy Virtual Congress 2021

Retrieved on: 
Tuesday, October 12, 2021
Generides, Company, Capsid, Saavi, ESGCT, Therapy, Poster, Presentation, Gene editing, European Society of Gene and Cell Therapy, Hepatocyte, Cell, AAV, DNA, Tissue, Vaccine

The oral presentation will include new preclinical GeneRide data showing delivery of corrective genes in three different indications with intrinsic liver damage demonstrating strong evidence of selective advantage of the corrected hepatocytes.

Key Points: 
  • The oral presentation will include new preclinical GeneRide data showing delivery of corrective genes in three different indications with intrinsic liver damage demonstrating strong evidence of selective advantage of the corrected hepatocytes.
  • Poster presentations will highlight GeneRide expression data in preclinical models of tyrosinemia type 1, as well as the company's optimized adeno-associated virus (AAV) process development.
  • The Company's gene editing platform, GeneRide, is a new approach to precise gene insertion harnessing a cell's natural DNA repair process potentially leading to durable therapeutic protein expression levels.
  • The Company's gene delivery platform, sAAVy, is an adeno-associated virus (AAV) capsid engineering platform designed to optimize gene delivery for treatments in a broad range of indications and tissues.

Morgan Solar Launches New IV DAQ & Analytics Portal

Retrieved on: 
Tuesday, August 3, 2021
Electromagnetism, Electricity, Electronics, IV, DAQ, Presentation, Semiconductor curve tracer, Current–voltage characteristic

TORONTO, Aug. 3, 2021 /PRNewswire/ --Morgan Solar is excited to announce the certification and launch of the IV-DAQ, an in-situ IV curve tracer, and complementary Analytics Portal.

Key Points: 
  • TORONTO, Aug. 3, 2021 /PRNewswire/ --Morgan Solar is excited to announce the certification and launch of the IV-DAQ, an in-situ IV curve tracer, and complementary Analytics Portal.
  • The IV DAQ provides accurate full IV curve traces as well as panel voltage, current, temperature and string current.
  • The web-based Analytics Portal captures data from the IV DAQ alongside other meteorological sensors, and presents a suite of tools for presentation and analysis.
  • Morgan Solar developed and used the IV DAQ for around 8 years to support its own module development.

Aerojet Rocketdyne Holdings, Inc. to Participate in Jefferies 2021 Industrials Conference on August 3

Retrieved on: 
Wednesday, July 28, 2021
California, Aerojet Rocketdyne Holdings, States of the United States, Canoga Park, Los Angeles, Rocketdyne, United Technologies, Aerojet Rocketdyne, Aerojet, El Segundo, California, Lluís Companys, Presentation slide, Presentation

EL SEGUNDO, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD) announced today that it will participate in the Jefferies 2021 Industrials Conference being held virtually on August 3, 2021.

Key Points: 
  • EL SEGUNDO, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD) announced today that it will participate in the Jefferies 2021 Industrials Conference being held virtually on August 3, 2021.
  • Chief Financial Officer Dan Boehle is scheduled to present at 8-8:25 a.m. PDT / 11-11:25 a.m. EDT.
  • A live webcast of the presentation and associated slide deck can be accessed through the companys website at https://ir.aerojetrocketdyne.com/events-and-presentations during the presentation, and they will be archived for 90 days.
  • More information can be obtained by visiting the Companys websites at www.rocket.com or www.aerojetrocketdyne.com .

Qynapse to Present Poster Presentations and Attend the Alzheimer's Association International Conference (AAIC) 2021 in Denver, USA and Online

Retrieved on: 
Monday, July 26, 2021
Visual arts, Articles, Poster session, Presentation, Research, Poster, Education

"We are very pleased to attend AAIC in-person in Denver this year to present and discuss our latest advances with the neuroscience community.

Key Points: 
  • "We are very pleased to attend AAIC in-person in Denver this year to present and discuss our latest advances with the neuroscience community.
  • We have made tremendous progress in 2021 towards expanding the commercialization of QyScore into new global markets and to strengthen our clinical trial offering.
  • Details of Poster Presentations using Qynapse technology:
    Poster ID and Session Name: Poster #51308.
  • QYNAPSE is headquartered in France, in the United States and in Canada.

Stantec to Release Second Quarter 2021 Results on August 4, 2021, and Host Conference Call on August 5, 2021

Retrieved on: 
Tuesday, July 6, 2021
Stantec, Slide show, STN, New York Stock Exchange, Presentation, Public sphere, Policy, Companies

EDMONTON, Alberta, July 06, 2021 (GLOBE NEWSWIRE) -- TSX,NYSE: STN

Key Points: 
  • EDMONTON, Alberta, July 06, 2021 (GLOBE NEWSWIRE) -- TSX,NYSE: STN
    Stantec will release its second quarter 2021 financial results after markets close on Wednesday, August4, 2021.
  • The webcast and slide presentation can be accessed at:
    The conference call and slideshow presentation will be broadcast live and archived in their entirety in the Investors section of stantec.com .
  • Participants wishing to listen to the call via telephone may dial in toll-free at 1-888-204-4368 (Canada and United States) or +1-647-484-0478 (international).
  • Balancing these priorities results in projects that advance the quality of life in communities across the globe.

Social Storytelling Platform PechaKucha Raises $2.7 Million in Seed Funding

Retrieved on: 
Tuesday, June 29, 2021
PechaKucha, Presentation, Storytelling, Engagement marketing, Articles

CHICAGO, June 29, 2021 /PRNewswire-PRWeb/ -- PechaKucha, Inc., a social storytelling platform that has been used by millions of people across the globe, today announces a Seed funding of $2.7 million to scale its platform for time-based connectivity and sharing among creators, professionals, and brands.

Key Points: 
  • CHICAGO, June 29, 2021 /PRNewswire-PRWeb/ -- PechaKucha, Inc., a social storytelling platform that has been used by millions of people across the globe, today announces a Seed funding of $2.7 million to scale its platform for time-based connectivity and sharing among creators, professionals, and brands.
  • "Our social storytelling platform keeps engagement authentic, human, and concise with time as our superpower."
  • Coinciding with the Covid-19 pandemic, PechaKucha launched a virtual storytelling platform that grew to over 100,000 beta users within nine months.
  • "PechaKucha's social storytelling platform supports content creators who seek to build strong communities and share stories for inspired outcomes.

DGAP-News: Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in July

Retrieved on: 
Monday, June 28, 2021
Poster session, Presentation, Research

The poster presentation will be accessible on the "Events and Presentations" section of Immunic's website at: ir.imux.com/events-and-presentations .

Key Points: 
  • The poster presentation will be accessible on the "Events and Presentations" section of Immunic's website at: ir.imux.com/events-and-presentations .
  • Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, will present a company overview on Tuesday, July 13, at 10:00 am ET.
  • Examples of such statements include, but are not limited to, statements relating to management's participation in scientific, industry and investor conferences.
  • Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release.

Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in July

Retrieved on: 
Monday, June 28, 2021
Poster session, Presentation, Research, Articles, Multimedia, Webcast, Telecommunications

The poster presentation will be accessible on the "Events and Presentations" section of Immunic's website at: ir.imux.com/events-and-presentations .

Key Points: 
  • The poster presentation will be accessible on the "Events and Presentations" section of Immunic's website at: ir.imux.com/events-and-presentations .
  • Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, will present a company overview on Tuesday, July 13, at 10:00 am ET.
  • A live audio webcast of the presentation will be available on the "Events and Presentations" section of Immunic's website at: ir.imux.com/events-and-presentations .
  • Examples of such statements include, but are not limited to, statements relating to management's participation in scientific, industry and investor conferences.

Medtronic Announces Real-World Data on InPen™ and Extended Infusion Set* Pivotal Trial Data at the American Diabetes Association 81st Scientific Sessions

Retrieved on: 
Wednesday, June 23, 2021
Medicine, Articles, Diabetes, Clinical medicine, Poster session, Presentation, Research, Medtronic, Glycemic, Onboarding, Infusion set, Insulin

Medtronic will be participating in this year's ADA virtual sessions with seven data presentations, a product theater, two on-demand learning sessions, and a virtual exhibit.

Key Points: 
  • Medtronic will be participating in this year's ADA virtual sessions with seven data presentations, a product theater, two on-demand learning sessions, and a virtual exhibit.
  • "Glycemic outcomes of new InPen smart insulin pen users who received virtual onboarding" poster presentation by Madison Smith, Ph.D., R.N.
  • "Infusion Set Survival and Performance During the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial" poster presentation by Bruce Buckingham, M.D.
  • "Patient Reported Satisfaction During the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial" poster presentation by Ron Brazg, M.D., FACE.